Minnesota Resource Allocation Platform For COVID-19 Treatment
For Health Care Providers
Monoclonal antibody treatments are available through the Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for non-hospitalized COVID-19 positive people.
Please note: providers submitting data on behalf of the patient are responsible for their own compliance with any health privacy laws or regulations that apply to them.
MN Resource Allocation Platform screening process
Fill out the MN Resource Allocation Platform screening form. The screening form takes approximately 10-15 minutes to complete. Before starting the screening form, please have with you:
- Medical records
- Patient contact information ready: address, phone number, email
- Important: Please ensure you have notified the patient of this submission and that they are interested in receiving treatment before entering their information. If the patient has declined treatment, you do NOT need to enter their information into this screening form.
- Minnesota Resource Allocation Platform for COVID-19 Treatment (platform overview)